We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Dr
Beata
Godlewska
beata.godlewska.ext@lindushealth.com
Ms
Trial
Lead
remedi@lindushealth.com
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record by the end date of the deferral (24 Jan 2026)
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
You can take part if:
You may not be able to take part if:
The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record by the end date of the deferral (24 Jan 2026)
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
This information has not yet been provided by the study team. You'll have an opportunity to discuss any risks and benefits that may be associated with this study prior to consenting to taking part.
The study is sponsored by Alfred E. Tiefenbacher (Germany) and funded by Alfred E. Tiefenbacher.
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
